Actinomyces lesions and acute inflammation predominate in osteonecrosis of the jaw associated with osteoclast-suppressing therapy in contrast to non-medication-related osteonecrosis

PURPOSE: Patients receiving antiresorptive therapy for cancer bone metastases/lesions or osteoporosis may develop osteonecrosis of the jaw. The pathogenesis remains unclear, but the condition has been associated with Actinomyces, co-pathogens, and pro-inflammatory activity. However, there are limited studies comparing these factors between medication-related osteonecrosis and non-medication-related osteonecrosis. METHODS: This is a single-centre retrospective study of 98 patients with jawbone biopsies due to medication-related osteonecrosis treated with bisphosphonates and/or denosumab, and 93 patients with non-medication-related osteonecrosis during 2002-2020. We reviewed their medical records and analysed tissue samples for Actinomyces colonies, inflammation and proinflammatory collagenase matrix metalloproteinase-8 (MMP-8) using immunohistochemistry. RESULTS: Actinomyces colonies were more prevalent in medication-related osteonecrosis (85%) compared to non-medication-related cases (51%; p < 0.001) and were mainly associated with necrotic bone. Inflammation was present in most samples; however, in medication-related osteonecrosis, it was predominantly acute (58%) and rarely chronic (5%), whereas in non-medication-related biopsies, inflammation was acute in 38% and chronic in 27% of biopsies (p < 0.001). Enhanced MMP-8 immunoreactivity was observed in 61% of medication-related osteonecrosis vs. 38% in non-medication-related biopsies (p = 0.002), and MMP-8 was especially expressed alongside actinomycotic lesions (57% vs. 34%; p < 0.001). In multivariable logistic regression, the medication-related group was independently associated with a higher prevalence of Actinomyces colonies. CONCLUSION: Medication-related osteonecrosis was independently linked to a higher prevalence of Actinomyces compared to non-medication-related osteonecrosis. Furthermore, acute inflammation and collagenase activity seemed to be effects of Actinomyces-associated infection. The presence of Actinomyces may suggest immunological differences between these osteonecrosis types.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Microbiology & Infectious Diseases
Published
2026-04-06
DOI
https://doi.org/10.1007/s10096-026-05501-9
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Actinomyces lesions and acute inflammation predominate in osteonecrosis of the jaw associated with osteoclast-suppressing therapy in contrast to non-medication-related osteonecrosis

Asko Järvinen, Hanna Välimaa, Jaana Hagström, Jussi Oskari Furuholm et al.
European Journal of Clinical Microbiology & Infectious Diseases
Bone health and treatments
article

Actinomyces lesions and acute inflammation predominate in osteonecrosis of the jaw associated with osteoclast-suppressing therapy in contrast to non-medication-related osteonecrosis

Asko Järvinen, Hanna Välimaa, Jaana Hagström, Jussi Oskari Furuholm, Caj Haglund, M Kivelä-Rajamäki, Timo Sorsa
article en

Abstract

PURPOSE: Patients receiving antiresorptive therapy for cancer bone metastases/lesions or osteoporosis may develop osteonecrosis of the jaw. The pathogenesis remains unclear, but the condition has been associated with Actinomyces, co-pathogens, and pro-inflammatory activity. However, there are limited studies comparing these factors between medication-related osteonecrosis and non-medication-related osteonecrosis. METHODS: This is a single-centre retrospective study of 98 patients with jawbone biopsies due to medication-related osteonecrosis treated with bisphosphonates and/or denosumab, and 93 patients with non-medication-related osteonecrosis during 2002-2020. We reviewed their medical records and analysed tissue samples for Actinomyces colonies, inflammation and proinflammatory collagenase matrix metalloproteinase-8 (MMP-8) using immunohistochemistry. RESULTS: Actinomyces colonies were more prevalent in medication-related osteonecrosis (85%) compared to non-medication-related cases (51%; p < 0.001) and were mainly associated with necrotic bone. Inflammation was present in most samples; however, in medication-related osteonecrosis, it was predominantly acute (58%) and rarely chronic (5%), whereas in non-medication-related biopsies, inflammation was acute in 38% and chronic in 27% of biopsies (p < 0.001). Enhanced MMP-8 immunoreactivity was observed in 61% of medication-related osteonecrosis vs. 38% in non-medication-related biopsies (p = 0.002), and MMP-8 was especially expressed alongside actinomycotic lesions (57% vs. 34%; p < 0.001). In multivariable logistic regression, the medication-related group was independently associated with a higher prevalence of Actinomyces colonies. CONCLUSION: Medication-related osteonecrosis was independently linked to a higher prevalence of Actinomyces compared to non-medication-related osteonecrosis. Furthermore, acute inflammation and collagenase activity seemed to be effects of Actinomyces-associated infection. The presence of Actinomyces may suggest immunological differences between these osteonecrosis types.

European Journal of Clinical Microbiology & Infectious Diseases
University of Helsinki (FI), University of Turku (FI), Helsinki University Hospital (FI), Karolinska Institutet (SE)
Helsingin Yliopisto
Good health and well-being
Openalex Percentile: Top 22%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.